Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diana Kim

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|March 19, 2022
Extra kinetic dimensions for label discriminationRaja Chouket, Agnès Pellissier-Tanon, Aliénor Lahlou, et al.
Clinical Lung Cancer|February 26, 2026
Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR DatabaseDiana Kim, Sarah Blocker, Courtney C Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practiceSarah Blocker, Diana Kim, Courtney C Cavalieri, et al.
Journal of the American Heart Association|October 23, 2025
Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke OutcomesUmberto Pensato, Johanna M Ospel, Jianhai Zhang, et al.
Cell Metabolism|October 13, 2015
A Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene Deletion Strains Uncovers Conserved Mechanisms of AgingMark A McCormick, Joe R Delaney, Mitsuhiro Tsuchiya, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Nature Communications|March 19, 2022
Extra kinetic dimensions for label discriminationRaja Chouket, Agnès Pellissier-Tanon, Aliénor Lahlou, et al.
Clinical Lung Cancer|February 26, 2026
Outcomes of Concurrent Radiotherapy With Tarlatamab in Extensive-Stage Small Cell Lung Cancer From the DLL3 PanTUMOR DatabaseDiana Kim, Sarah Blocker, Courtney C Cavalieri, et al.
European Journal of Cancer (Oxford, England : 1990)|March 25, 2026
Risk factors for CRS and ICANS with tarlatamab in small cell lung cancer and associated efficacy outcomes: Insights from clinical practiceSarah Blocker, Diana Kim, Courtney C Cavalieri, et al.
Journal of the American Heart Association|October 23, 2025
Association of Minimal Clinically Important Difference With Infarct Volume in Clinical Poststroke OutcomesUmberto Pensato, Johanna M Ospel, Jianhai Zhang, et al.
Cell Metabolism|October 13, 2015
A Comprehensive Analysis of Replicative Lifespan in 4,698 Single-Gene Deletion Strains Uncovers Conserved Mechanisms of AgingMark A McCormick, Joe R Delaney, Mitsuhiro Tsuchiya, et al.
Pageof 3